2 results
Approved WMOCompleted
The objective of the current study is to assess the effect of speed optimization on clinical and echocardiographic parameters at 3 months follow-up.
Approved WMOCompleted
Lu AF28996 is an orally administered investigational compound of a potent, long-acting dopamine agonist, Lu AA40326, currently under development by H. Lundbeck A/S for the treatment of Parkinson*s disease (PD). Primary Objective:to investigate theā¦